According to reports from America, diabetes company Medtronic Inc is upping their investment in diabetes . The company is increasingly looking to boost levels of people with diabetes who use insulin pumps and continuous glucose monitors .
Medtronic are the largest stand-alone medical device manufacturer in the world. The company is looking to increase diabetes technology spend by 35 per cent this year, the aim being to create next-generation devices that are easier to use and manage diabetes more efficiently.
Two exciting new products that are expected to be approved soon include an insulin pump with a safety feature that shuts off insulin delivery when blood sugar goes too low, and an insulin ‘patch’ pump to eliminate pump tubing.
Diabetes company foresee device growth
Tue, 01 Jul 2008
Recommended links
Diabetes newsletterDiabetes based financial services
Diabetes forum
Diabetes signs and symptoms
Useful diabetes car developed
Diabetes high amongst UK children
Company sets up diabetes research fund
Diabetes drug company say efficiency is proven
Diabetes company get Canadian approval
Pfizer in major bid for drug company
Diabetes Company says new drug is efficient
Diabetes company shares hit a low
Diabetes drug company shares climb
Diabetes company faces further controversy
Diabetes drug company sales fall
Company gets boost in diabetes battle
Diabetes Drug Company losing less
Drug company will continue diabetes trial
Diabetes company profits continue to climb
